Professor Commentary Module II (Part 2)

511 views
460 views

Published on

Part 2 of the commentary for Module 6, Qualitative Research, is the PowerPoint for Chapter 16 of the text.

Published in: Economy & Finance, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
511
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Professor Commentary Module II (Part 2)

  1. 1. Chapter 6 Drug Therapy in the 21st Century
  2. 2. Changes in Health Care in the 21 st Century <ul><li>Access to medical and pharmacologic information is available from many sources </li></ul><ul><li>Consumers are taking steps to demand specific treatments and considerations </li></ul><ul><li>Alternative therapies are being offered and advertised </li></ul><ul><li>Financial pressures are leading to early discharge </li></ul><ul><li>Patient teaching and home care provisions are vital </li></ul>
  3. 3. Federal Guidelines—Drug Advertising <ul><li>When the advertisement states the indication, it must also include: </li></ul><ul><ul><li>Contraindications </li></ul></ul><ul><ul><li>Adverse effects </li></ul></ul><ul><ul><li>Precautions </li></ul></ul>
  4. 4. Internet Sources for Drug Information <ul><li>Pharmaceutical company information sites </li></ul><ul><li>Chat rooms with other people who are taking the drug </li></ul><ul><li>Online pharmacies </li></ul><ul><li>Lists of government regulations </li></ul><ul><li>Research reports about the drug and its effectiveness </li></ul>
  5. 5. Internet Site Evaluation <ul><li>Navigation </li></ul><ul><ul><li>Is the site easy to access and navigate or confusing? </li></ul></ul><ul><li>Contributor </li></ul><ul><ul><li>Who prepared the site and what are his qualifications? Is it reviewed, or is it purely commercial? </li></ul></ul><ul><li>Dates </li></ul><ul><ul><li>Is the site updated frequently? </li></ul></ul><ul><li>Accuracy/reliability </li></ul><ul><ul><li>Is the information supported by other sites, accurate, and in agreement with other sources you have reviewed? Are other links listed? </li></ul></ul>
  6. 6. Problems Associated With OTC Medications <ul><li>Can mask the signs and symptoms of disease </li></ul><ul><li>Can interact with prescription drugs </li></ul><ul><li>Can be taken in greater than the recommended dose, leading to toxicity </li></ul>
  7. 7. Over-the-Counter Drugs <ul><li>Drugs that were “grandfathered” in </li></ul><ul><li>Former prescription drugs that have been tested and found to be safe for the general public if used as directed </li></ul>
  8. 8. Alternative Therapy Drawbacks <ul><li>The active ingredient has not been tested by the FDA </li></ul><ul><li>Incidental ingredients are unknown </li></ul><ul><li>Patients do not always mention these therapies to their health care providers </li></ul><ul><li>Drug–alternative therapy interactions may occur </li></ul>
  9. 9. Controls for Alternative Therapy <ul><li>Herbal medications and alternative therapies are not controlled or tested by the FDA </li></ul><ul><li>Advertisement for these drugs is not restricted because they are considered dietary supplements </li></ul><ul><li>No regulation by any industry </li></ul>
  10. 10. Off-Label Medications <ul><li>Definition </li></ul><ul><ul><li>The use of a drug for an indication that is not approved by the FDA </li></ul></ul><ul><li>Occurrence </li></ul><ul><ul><li>Commonly takes place in groups of patients for whom there is little premarketing testing </li></ul></ul><ul><ul><li>Used with pediatric and geriatric populations </li></ul></ul>
  11. 11. Health Care in Crisis <ul><li>Skyrocketing cost of medical care and drugs </li></ul><ul><li>Huge research and equipment requirements to meet consumer demands </li></ul><ul><li>Rising cost of health insurance </li></ul><ul><li>Earlier discharge from hospitals </li></ul>
  12. 12. Measures to Protect the Public From Bioterrorism <ul><li>Emergency preparedness at all levels of the government </li></ul>
  13. 13. Treatments for Exposure to Biological/Chemical Weapons <ul><li>Insert table 6.3 </li></ul>

×